Vitamin D and respiratory infection risk: what the research actually shows

Vitamin D plays a genuine, well-documented role in immune function, including in the airway's local immune defenses against respiratory pathogens, and observational studies consistently show that people with low vitamin D levels have higher rates of respiratory infections than people with adequate levels — this correlation is well-established and shows up across multiple studies and populations.

The harder, more clinically relevant question is whether correcting a deficiency through supplementation actually reduces infection risk going forward, and here the evidence is more nuanced: some large trials have shown a modest reduction in respiratory infection risk from vitamin D supplementation, but the effect appears concentrated specifically in people who were significantly deficient to begin with, with much less clear benefit for people who already have adequate or borderline-adequate levels supplementing further.

This distinction — correcting a real deficiency versus supplementing beyond adequate levels — is where a lot of the public confusion around vitamin D and immunity comes from, since headlines summarizing these trials don't always preserve that nuance. It's also why testing actual vitamin D levels before starting supplementation is a more useful approach than assuming a standard dose benefits everyone equally regardless of their starting point.

For people with chronic respiratory conditions specifically, where respiratory infections carry higher stakes than they do for an otherwise healthy person, checking vitamin D status as part of routine care is a reasonable, low-cost step, and correcting a genuine deficiency if one is found has real supporting evidence behind it — the caveat is treating this as a deficiency-correction question specific to that individual's actual lab values, not a general supplement recommendation for everyone regardless of their baseline level.